Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access type 1 diabetes specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 1 diabetes treatment provided free
Type 1 diabetes (T1D) arises from abnormal immune cell-mediated injury to beta cells that make insulin. The injured beta cells can then no longer make the needed amount of insulin to stay healthy. However, in the early stages of T1D, some beta cells are still alive and functioning. Treatment to protect the beta cells against injury at this time could slow the progress of disease. Denosumab is an approved treatment for osteoporosis (a disease that thins and weakens the bones), high blood calcium
Sponsor: City of Hope Medical Center
Check if you qualify for this type 1 diabetes clinical trial in Indianapolis, IN
If you're searching for type 1 diabetes treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.